Renee Maria Saliby
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
Renee Maria Saliby
Apr 23, 2024, 16:24 |
Blog
Renee Maria Saliby: Enthusiastic about joining Yale Traditional Internal Medicine Program after listening to the 'State of the Cancer Center' by Eric Winer
Renee Maria Saliby, Postdoctoral GU Oncology Research Fellow at Dana-Farber Cancer Institute, shared a post on…
Apr 8, 2024, 22:02 |
Insight
Renee Maria Saliby: Our paper 'Impact of RCC molecular subtypes on immunotherapy and targeted therapy outcomes' is now published in Cancer Cell
Renee Maria Saliby, Postdoctoral GU Oncology Research Fellow at Dana-Farber Cancer Institute, shared a post on…
Feb 2, 2024, 17:49 |
Blog
Renee Maria Saliby: Type and timing of antibiotics matters on outcomes of ICIs in patients with mUC
Renee Maria Saliby, Postdoctoral GU Oncology Research Fellow at Dana Farber, shared a post on X/Twitter:…
Jan 16, 2024, 01:08 |
Blog
Renee Maria Saliby: Always grateful and fortunate to have David Braun's guidance
Renee Maria Saliby, Postdoctoral GU Oncology Research Fellow at Dana-Farber Cancer Institute, made the following…
Oct 25, 2023, 18:50 |
Blog
Emre Yekedüz: Our results including more than 20,000 patients were presented as a poster at ESMO23
Quoting Emre Yekedüz, Associate Professor of Medical Oncology at Ankara University, on X/Twitter: ''Our results…
All:
5
Posts:
1 - 10
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Barbara Jereczek-Fossa has been elected as the ESTRO President-elect!
Facebook
RSS Feed
Twitter
Linkedin
Youtube